Next Article in Journal
Microstructure Evolution and Mechanical Stability of Retained Austenite in Thermomechanically Processed Medium-Mn Steel
Next Article in Special Issue
Oxidation Protective Hybrid Coating for Thermoelectric Materials
Previous Article in Journal
Bio-Inspired 3D Infill Patterns for Additive Manufacturing and Structural Applications
Previous Article in Special Issue
Development and Characterization of Bioactive Glass Containing Composite Coatings with Ion Releasing Function for Antibiotic-Free Antibacterial Surgical Sutures
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Studies on Cell Compatibility, Antibacterial Behavior, and Zeta Potential of Ag-Containing Polydopamine-Coated Bioactive Glass-Ceramic

Institute of Biomaterials, University of Erlangen-Nuremberg, 91058 Erlangen, Germany
Colorobbia Consulting s.r.l., 50053 Sovigliana Vinci, Florence, Italy
Department of Applied Science and Technology, Politecnico di Torino, 10129 Torino, Italy
Centre for Medical Physics and Technology, University of Erlangen-Nuremberg, 91052 Erlangen, Germany
Authors to whom correspondence should be addressed.
Materials 2019, 12(3), 500;
Submission received: 23 December 2018 / Revised: 18 January 2019 / Accepted: 29 January 2019 / Published: 6 February 2019
(This article belongs to the Special Issue Advanced Glasses, Composites and Ceramics for High Growth Industries)


Dopamine is a small molecule that mimics the adhesive component (L-DOPA) of marine mussels with a catecholamine structure. Dopamine can spontaneously polymerize to form polydopamine (PDA) in a mild basic environment. PDA binds, in principle, to all types of surfaces and offers a platform for post-modification of surfaces. In this work, a novel Ag-containing polydopamine coating has been developed for the functionalization of bioactive glass-ceramics. In order to study the interactions between the surface of uncoated and coated samples and the environment, we have measured the surface zeta potential. Results confirmed that PDA can interact with the substrate through different chemical groups. A strongly negative surface zeta potential was measured, which is desirable for biocompatibility. The dual function of the material, namely the capability to exhibit bioactive behavior while being antibacterial and not harmful to mammalian cells, was assessed. The biocompatibility of the samples with MG-63 (osteoblast-like) cells was determined, as well as the antibacterial behavior against Gram-positive Staphylococcus carnosus and Gram-negative Escherichia coli bacteria. During cell biology tests, uncoated and PDA-coated samples showed biocompatibility, while cell viability on Ag-containing PDA-coated samples was reduced. On the other hand, antibacterial tests confirmed the strong antimicrobial properties of Ag-containing PDA-coated samples, although tailoring of the silver release will be necessary to modulate the dual effect of PDA and silver.

1. Introduction

The average life expectancy of humans is increasing worldwide thanks to advances in medicine and science. As a consequence, there has been an increase in osteoarthritis and other pathologies in elderly people, who consequently require orthopedic and dental implants [1]. The introduction of implants has the intrinsic risk of microbial infection, which can lead to implant failure. Bacterial infections are becoming more difficult to treat due to antimicrobial resistance (AMR). In the European Union, which has a population of ~500 million people, there are about 25,000 deaths per year due to bacterial infections [2]. Not only does this represent an unacceptable loss of lives, it carries an economic burden; if AMR is not controlled, the annual global gross domestic product will lose 3.8% by 2050 [3]. New approaches must therefore be put forward to prevent bacterial colonization of different surfaces, thus limiting the spread of infections.
Numerous biomaterials have been developed over the years for the application as orthopedic or dental implants, including stainless steel 316 L, cobalt-based alloys, titanium and its alloys, polymers, glass-ceramics and bioactive glasses, and their composites [1]. Among these, bioactive glasses and glass-ceramics have received much attention, because of their desirable mechanical properties and their capability to interact with hard [4,5] and soft tissues [6].
Surface functionalization offers the possibility to tailor the properties of a material’s surface to obtain an optimal interface between the substrate and the biological environment [7]. Since the discovery of the outstanding properties of polydopamine [8], several materials have been coated with this oligomer, which mimics the molecules found near the plaque–substrate interface of mussels [8,9,10]. Thanks to the presence of catechol, amine, and imine moieties in its structure, polydopamine can undergo further functionalization by electroless metallization with copper or silver [11,12]. Silver nanoparticles and nanocomposites are well known for their strong antibacterial capabilities [13,14]. Silver has been also shown to be non-cytotoxic to human cells [13,14,15].
The incorporation of silver in bioactive glasses has been investigated for many years [16,17,18]. This is usually achieved by the sol-gel technique; another option is to coat the surfaces with silver using different techniques such as plasma spraying, molten salt ion exchange, or sputtering [16,17,19,20].
Coatings, based on polydopamine incorporating silver particles, represent an attractive approach to obtain dual-functional composite layers on the surface of biomaterials. Such composites should facilitate interactions with biological tissues without showing cytotoxicity and also exhibit antibacterial capability [21,22,23,24,25]. In our previous study [26], Ag-containing polydopamine coatings on bioactive glass-ceramic surfaces were developed; however, only a limited characterization of the coatings has been reported. In this work, such coatings have been characterized by testing their biocompatibility. We have carried out antibacterial tests against Gram-positive Staphylococcus carnosus and Gram-negative Escherichia coli bacterial strains. We have further conducted studies regarding the surface zeta potential of the samples and hypothesize that due to the presence of several chemical moieties, polydopamine can bind differently to different biomaterials depending on the characteristics of the substrate.

2. Materials and Methods

2.1. Fabrication of the Samples and Structural Characterization

All tests were performed on sintered glass-ceramic (labelled BGC1) pellets, uncoated and coated with PDA and PDA@Ag (BGC1@PDA, BGC1@PDA@Ag), of which the details are described elsewhere [26]. Briefly, we produced a melt-derived glass of the nominal composition BGC1 (in wt%): 47.8% SiO2, 4.9% Na2O, 0.4% K2O, 30.6% CaO, 2.9% MgO, 11.8% P2O5, and 1.6% CaF2. Ground BGC1 powder was then cold-pressed at 0.7 MPa for 30 s to form cylindrical pellets with a diameter of 11 mm and a height of 3 mm. The pellets were sintered at 860 °C for 30 min. In order to coat the pellets with polydopamine, sintered pellets were immersed for 24 h in aqueous solution of dopamine hydrochloride (Sigma-Aldrich, Schnelldorf, Germany) in Tris-buffer solution (Tris(hydroxymethyl) aminomethane, Sigma-Aldrich, Schnelldorf, Germany). The solution’s pH value was adjusted to pH 8.5 using HCl 1 M. The pellets were then thoroughly rinsed with deionized water. Additionally, the PDA-coated pellets (BGC1@PDA) were further functionalized by immersing them for 24 h in an aqueous solution of AgNO3 5 × 10−3 M (Sigma-Aldrich, Schnelldorf, Germany). BGC1@PDA@Ag pellets were then rinsed with deionized water and allowed to dry in normal air.
The surface roughness was measured for each type of coating by using a laser profilometer (UBM Microfocus Expert, ISC-2). A measurement length of 5 mm was used with a scanning velocity of 400 points per second. The mean roughness (Ra) and maximum roughness (Rmax) were calculated using the LMT Surface View UBM software (UBM Messtechnik GmbH, Ettlingen, Germany). Ra is calculated as the average roughness of the coating’s surfaces by measuring microscopic peaks and valleys, while Rmax is calculated by measuring the vertical distance from the highest peak to the lowest valley. Three samples were measured for each type of coating, and mean values of Ra and Rmax were reported with standard deviation.
Morphological analysis of the samples, prior to and after coating, was performed by means of scanning electron microscopy (SEM) (Auriga SEM instrument Zeiss, Oberkochen, Germany). Samples were sputter-coated with gold in vacuum.

2.2. Surface Zeta Potential

The zeta potential of the samples was measured by means of the streaming potential technique, using an electrokinetic analyser (SurPASS, Anton Paar, Graz, Austria) equipped with an adjustable gap cell. All measurements were performed in simulated body fluid (SBF) [27], which was diluted in ultrapure water up to a pH of about 7.4 and had a conductivity close to 16 mS·m−1 (measured by the monitoring function of the instrument), without pH titration during measurements. For the analyses, two cylindrical samples (11 mm diameter, 3 mm height) were prepared for each type (bare BGC1, BGC1@PDA and BGC1@PDA@Ag) and mounted parallel to each other on the sample holder of the cell. The gap was adjusted close to 100 μm and the electrolyte flow to approximately 100 mL·min−1. The zeta potential values were obtained from measured streaming currents using the Helmholtz–Smoluchowski Equation (1):
ζ = dU dp × η ϵ × ϵ 0 × κ B ,
where dU/dp is the slope of streaming potential vs. differential pressure, η is electrolyte viscosity, ε is dielectric coefficient of electrolyte, ε0 is permittivity, and κB is electrolyte conductivity.

2.3. Preconditioning of the Samples

Uncoated BGC1 pellets were sterilized by dry heat (160 °C for 2 h). The samples were placed in a 24-well plate and covered with 1 mL DMEM (+10% FBS, +1% penicillin/streptomycin (PS)). The pH of the medium was measured after 1, 2, 3, 4, 7, and 8 days. Measurements were made in duplicate and the average was calculated. After the measurements, the medium was removed and fresh medium was added. The preconditioning of the samples was carried out under sterile conditions.

2.4. Cell Biology Studies

2.4.1. Cell Seeding and Culture

MG-63 (osteoblast-like) cells (Sigma-Aldrich, Schnelldorf, Germany) were used. The cells were cultured at 37 °C in an atmosphere of 95% humidified air and 5% CO2, in Dulbecco’s modified Eagle’s medium (DMEM; Gibco, ThermoFisher Scientific, Waltham, MA, USA) supplemented with 10 vol % fetal bovine serum (FBS; Gibco, Germany) and 1% of penicillin/streptomycin (PS; Gibco, ThermoFisher Scientific, Waltham, MA, USA). Cells were grown to 80% confluence in 75 cm2 culture flasks, washed with phosphate buffered saline and detached using trypsin/EDTA (Sigma-Aldrich, Schnelldorf, Germany). Cells were counted by a hemocytometer (Neubauer improved) and diluted with culture medium to a final concentration of 1 × 105 cells/mL. Subsequently, 1 mL of cell solution was seeded in direct contact in a 24-well cell culture plate. To ensure statistical significance, eight replicates of each sample type were performed.

2.4.2. Cell Viability

The viability of MG-63 cells was assessed using the WST-8 assay kit (Sigma-Aldrich, Schnelldorf, Germany). WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt) is reduced by cellular dehydrogenase to a formazan product, which is directly proportional to the number of living cells.
After 48 h of incubation, the culture medium was completely removed, and samples were washed with PBS. Subsequently, 0.25 mL of WST-8 medium (containing 1 vol % of WST-8 reagent and 99 vol % of DMEM medium) was added and incubated for 2 h. Afterwards, 100 μL of supernatant from each sample was transferred into a well of a 96-well plate, and the absorbance at 450 nm was measured with a microplate reader (PHOmo, Autobio Labtec Instruments Co. Ltd., Zhengzhou, China). From the obtained absorbance, the cell viability was calculated by taking the absorbance of each specimen (Ai) and of the respective control (A0) as follows:
Cell   viability ( % ) = A i A 0 × 100 ,

2.4.3. Cell Morphology

To visualize the adhered cells on the samples, green Calcein AM (calcein acetoxymethyl ester, Invitrogen, ThermoFisher Scientific, Waltham, MA, USA) cell-labelling solution was used to stain the cytoplasm of the cells. Cell culture medium was removed and 0.25 mL of staining solution containing 0.5 vol % of dye-labelling solution and 99.5 vol % of PBS was added to the samples and incubated for 30 min. Afterwards, the solution was removed and the samples were washed with 0.5 mL PBS. Cells on the surface were fixed by 3.7 vol % paraformaldehyde. Samples were washed with PBS again and blue fluorescent DAPI (4′,6-diamidino-2-phenylindole dihydrochloride, Roche, Basel, Switzerland) was added to stain the nucleus. The samples were incubated for 5 min, and the solution was removed. The samples were left in PBS for microscopic viewing, using a fluorescence microscope (Axio Scope, ZEISS, Jena, Germany).

2.5. Statistical Analysis

The differences in analytical parameters between the different samples were analyzed by one-way analysis of variance (ANOVA). The significance level was set as * p < 0.05, ** p < 0.01 and *** p < 0.001. For comparison of the mean values, the Tukey post hoc test was used (N = 8).

2.6. Antibacterial Tests

A direct contact bacterial assay was performed on uncoated and coated BGC1 pellets. The dimensions of the pellets were 10 mm (diameter) and 2 mm (height). The samples were tested before and after a pre-incubation time of 8 days in DMEM (Dulbecco’s modified Eagle’s medium) to maintain the same conditions as in the case of cell viability tests.
Prior to coating the samples, they were dry-sterilized in an oven at 160 °C for 2 h. Afterwards, the samples were coated as described elsewhere [26]. After the coating of the samples, they were sterilized by UV irradiation for 1 h.
Gram-positive Staphylococcus carnosus and Gram-negative Escherichia coli were chosen as test bacterial strains. Isolated colonies of both Gram-positive and Gram-negative bacteria were suspended in 10 mL of lysogeny broth (LB #968.1, Carl Roth GmbH) and grown overnight in an orbital shaker at 100 rpm at 37 °C.
The next day, the fresh bacteria suspension was diluted to an optical density of 0.015 at 600 nm (OD600) (Biophotometer Plus, Eppendorf AG, Hamburg, Germany).
Uncoated and coated samples were placed in a 24 well-plate with 2 mL of LB, and fresh bacteria suspension was inoculated into the samples and put in the incubator at 37 °C. Optical density (OD600) was measured after 1, 4, 8, 24, and 48 hours. To ensure statistical significance, three replicates of each sample type were performed. In addition, bacterial cultures were done in duplicate, on different days.

3. Results and Discussion

3.1. Structural Characterization

The surface roughness was measured, and results are summarized in Table 1. It can be seen that for all samples the roughness is quite homogeneous. In this case, the roughness measurements are related to the substrate only, since polydopamine coating has been determined to be ~50 nm in thickness, as reported in literature [9,28]. In this way, for the roughness measurements, the influence of the substrate would be more significant than the polydopamine film itself.
In order to study the morphology of the surface, SEM micrographs were obtained (Figure 1). In the case of BGC1, it is possible to observe sharpened microcrystals (Figure 1A,B), although the overall surface is quite homogeneous. For BGC1@PDA, the surface is smoother, probably due to the deposition of polydopamine (Figure 1C,D), which forms spherical aggregates. After the deposition of silver onto the surface of the coated bioactive glass-ceramic, some silver aggregates are visible, being well distributed on the surface (Figure 1E,F).

3.2. Surface Zeta Potential

The contact between a solid surface and a water-based medium leads to the development of a surface charge at the interface. This charge is one of the surface characteristics, which could affect the interaction between the material and the biological environment (e.g., protein adsorption, cellular, and bacterial adhesion) [29]. In this context, zeta potential measurements were carried out to determine the surface charge at physiological pH (about 7.4). The pH of an aqueous solution is the driving force for an acid-base reaction, meaning that at high pH values, the dissociation of acidic groups will be enhanced while the protonation of basic groups will be suppressed, and vice versa.
The surface charge on polydopamine films is probably due to quinone imine and catechol groups [30]. More specifically, the positive or negative surface charges may arise from the reversible dissociation and deprotonation/protonation of amine and catechol groups, featuring PDA zwitterionicity [10]. It has been reported in the literature that the overall charge of PDA coatings is negative, although there is no general agreement regarding the zeta potential value; values reported vary between −4.58 mV (at pH = 7) and −39 mV (in Tris-buffer at pH = 8.5) [30,31,32,33], which can strongly depend on the measurement conditions (pH, electrolyte). Obtained results on surface zeta potential measurements are summarized in Table 2.
For uncoated BGC1, we obtained a highly negative zeta potential value (−120 ± 9 mV). Such negative surface charge at physiological pH is in accordance with the acidic isoelectric point of silica-based bioactive glasses [34]. Moreover, the negative surface charge of BGC1 is likely the result of the presence of siloxane (Si–OH) groups and hydroxyapatite (Ca5(PO4)3(OH)) on the surface (Figure 2), which in the presence of an aqueous solution at pH ~7.4 remains negatively charged. The negative surface charge of the glass-ceramic BGC1 could enhance the affinity and adhesion of cells. It has been reported that strongly negative surface charges promote the adsorption of specific proteins, leading to increased cell adhesion [35].
When BGC1 was modified with PDA, the value of the zeta potential at physiological pH remained negative, but its absolute value was reduced (−83 ± 1 mV) with respect to uncoated BGC1. It is possible that, thanks to the presence of PDA, positive ions were attracted from the solution (for example Ca2+), increasing the positive charge of the surface; this is in accordance with the literature [36,37,38]. However, this hypothesis is unlikely in the present case because, due to the high dilution of SBF, the availability of Ca2+ is relatively low.
It has been proposed in the literature that polydopamine could interact with aqueous solutions through various mechanisms due to its molecular structure [39]. If PDA binds differently, it means that exposed chemical groups would be different. Therefore, it is possible that for BGC1, polydopamine binds through OH groups from quinone, leaving more amine groups exposed to the aqueous environment and thus provoking the coated surface to become less negative.
With the introduction of silver onto the surfaces of PDA-modified samples (BGC1@PDA@Ag), the value of the zeta potential becomes slightly more negative (−98 ± 1 mV) than for BGC1@PDA. This behavior could be explained by the presence of silver particles which possess negative zeta potential, as described in the literature for silver nanoparticles [40,41,42] and for coatings containing silver nanoparticles at the investigated pH [43].
In summary, the measurements reported here evidence a strong negative charge on all tested surfaces in physiological conditions. The absolute value of these charges can depend on the typology and distribution of the surface functional groups as well as on their acidity strength and on their effect on surface wettability. However, a clear attribution of these differences cannot be obtained by measurements at a fixed pH; indeed, a zeta potential titration as a function of pH should be performed in future works to clarify this point.

3.3. Preconditioning of the Samples

Figure 3 shows the comparison of pH variation in DMEM and in SBF in contact with uncoated BGC1 pellets as a function of time. It must be taken into account that in the case of DMEM, the medium was changed every day, while for SBF the medium was not changed. Both measurements were carried out under static conditions. Observing the behavior in SBF, it is quite clear that a chemical process is occurring at the surface of BGC1 as already proved elsewhere [26]. In this work, the selected medium for pre-treatment was DMEM, since it is the medium used in cell biology tests. The preconditioning time needed for the pH to be lower than 7.75 was selected as 8 days, which is in good agreement with the work of Verné et al. [44]. The limit for the pH value, set to be lower than pH 7.75, has been established as an optimal value for the adhesion of osteoblasts [45]. The duration of the preconditioning treatment, namely 8 days, was relatively short. DMEM does not seem to provoke an extreme reaction at the surface of BGC1. Since BGC1 has a low content of Na2O (4.9%), a rapid exchange of sodium ions is not expected, which would cause a detrimental burst of local pH increase. Finally, the morphology of the samples also plays an important role in determining their bioreactivity [46]. It should be noted that in this study we have used BGC1 in the form of dense pellets, which exhibit a slower rate of ion exchange (bioreactivity) compared, for example, with porous materials or powders, which have much higher surface areas.

3.4. Cell Biology Studies

The viability of MG-63 cells cultured onto BGC1, BGC1@PDA, and BGC1@PDA@Ag samples for 48 hours was determined by WST-8 assay, and the results are shown in Figure 4. The bioactive glass-ceramic BGC1 showed, as expected, good compatibility with mammalian cells. Sintered BGC1 was determined to have a glassy matrix (15.8%) and the following crystalline phases: hydroxyapatite (47.6%), wollastonite (28.7%), and cristobalite (7.9%) [26]. An important phase in BGC1 is wollastonite. This crystalline phase has compatibility with bone tissue, as described in literature [47]. In the same way, hydroxyapatite and glass-ceramic implants have shown favorable interactions with marrow stromal cells [48,49,50]. Figure 5 shows fluorescence microscope images of MG-63 cells after 48 hours of direct culture. For BGC1, it was difficult to determine the morphology of the cells because of the brightness of the surface. However, the surface is seen to be completely covered by cells.
Polydopamine has been proven to have good cell compatibility, mostly due to (among other properties) its hydrophilicity, stiffness, and surface charge [9,10,51,52]. Figure 4 shows a slight suppression of cell viability for BGC1@PDA, which can be related to a modification of the surface roughness during the coating process. It is important to highlight that there is a strong influence of the substrate, since the polydopamine coating on BGC1 does not form a continuous film, reaching only 50 nm of thickness. Ryu et al. determined that polydopamine surfaces lead to mammalian cell proliferation without toxicity [36]; in addition, Chien and Tsai described that polydopamine does not support the adhesion of all types of cells [53]. On this basis, the lower number of cells on BGC1@PDA samples compared to BGC1 may not be related to cell death, but to a lower rate of proliferation. On the other hand, it can be seen in Figure 5 that cells spread well on BGC1@PDA surfaces and were interconnected to each other, which is an expected behaviour of bioactive materials.
BGC1@PDA@Ag samples exhibited a strong decrease in cell viability (52%). Fluorescence microscope images (Figure 5) show that cells are round shaped, which indicates cell stress. It is possible to observe calcein-stained cells, which means that cells are alive but under high stress. Forte et al. [24] used polydopamine as an interface between calcium phosphate and silver. It was also found that for certain samples coated with silver, cell toxicity occurred [24]. Therefore, more research efforts should be undertaken to optimize the silver dose to obtain an effective dual-function material.

3.5. Antibacterial Test

Figure 6 shows antibacterial test results against S. carnosus (Gram-positive) and E. coli (Gram-negative) bacteria strains after 48 hours of incubation in LB medium. For the test carried out against S. carnosus, BGC1 and BGC1@PDA did not show a significant effect on the growth of bacteria suspended in the medium. The preconditioning of the samples was important to confirm that there was no increase of local pH for BGC1, because of the lack of any dissolution process within the measuring time period, avoiding bacterial death. In the case of BGC1@PDA, since polydopamine confers hydrophilicity to the samples and does not have an active antimicrobial component, no significant antibacterial effect was observed. This result is in good agreement with the literature, as reports have shown that polydopamine coating itself has no antimicrobial effect against Gram-positive bacteria strains [25].
For the test carried out against E. coli, it seems that both BGC1 and BGC1@PDA inhibited the growth of bacteria after 24 hours of incubation. There is a controversy in literature, as some authors have described that polydopamine has an intrinsic antimicrobial effect, which is relatively weak against E. coli [32,54]. Meanwhile, some other works have determined that polydopamine itself does not show an antibacterial effect against E. coli [55]. In Figure 6 it is possible to observe a similar trend for both samples (BGC1 and BGC1@PDA), rejecting the hypothesis that polydopamine itself presents antimicrobial properties.
The tests carried out on BGC1@PDA@Ag samples against both S. carnosus and E. coli showed that the material is able to strongly reduce the growth of both chosen bacterial strains, as expected. A similar effect has been reported in the literature, in which several materials have been surface-modified with polydopamine and silver particles [10,21,25,32,56,57].

4. Conclusions

A bioactive glass-ceramic, BGC1, and the functionalized samples, BGC1@PDA and BGC1@PDA@Ag, showed a strongly negative surface zeta potential, which is desirable for in vitro biocompatibility. Tests carried out with the MG-63 cell line demonstrated the non-toxicity of BGC1 and BGC1@PDA. BGC1@PDA@Ag showed a moderate biocompatibility. Antibacterial tests indicated that BGC1@PDA@Ag possess a strong antimicrobial effect against both Gram-positive and Gram-negative bacterial strains. An antibacterial effect of PDA was not observed in the present experiments.
These promising findings encourage further investigations, which should lead to the tailoring of silver content in PDA-modified bioactive glass-ceramic to obtain a dual-function composite with strong antibacterial activity and non-toxicity for mammalian cells.

Author Contributions

R.T.-R. conceived the initial idea with A.R.B. and G.B.; R.T.-R. carried out the experiments and wrote the paper; A.G. and R.D. provided support during cell culture and later during the characterization, as well as analysis of the data; the antibacterial tests were carried out in the laboratory of W.H.G., who provided data evaluation; the surface zeta potential measurements were carried out in the laboratories of the Department of Applied Science and Technology, Politecnico di Torino, Italy, under the supervision of S.F. and S.S., who provided data evaluation. All authors checked the manuscript, provided necessary corrections and gave intellectual input.


This research was carried out within the EU Horizon 2020 framework project COACH (ITN-ETN, Grant agreement 642557).

Conflicts of Interest

The authors declare no conflict of interest.


  1. Mantripragada, V.P.; Lecka-Czernik, B.; Ebraheim, N.A.; Jayasuriya, A.C. An overview of recent advances in designing orthopedic and craniofacial implants. J. Biomed. Mater. Res. Part A 2013, 101, 3349–3364. [Google Scholar] [CrossRef] [PubMed]
  2. European Centre for Disease Prevention and Control; European Medicines Agency. The Bacterial Challenge: Time to React; European Centre for Disease Prevention and Control: Stockholm, Sweden, 2009. [Google Scholar] [CrossRef]
  3. World Bank Group. Drug-Resistant Infections: A Threat to Our Economic Future; World Bank Group: Washington, DC, USA, 2017. [Google Scholar] [CrossRef]
  4. Kokubo, T. Bioactive glass ceramics: Properties and applications. Biomaterials 1991, 12, 155–163. [Google Scholar] [CrossRef]
  5. Peitl, O.; Zanotto, E.D.; Hench, L.L. Highly bioactive P2O5–Na2O–CaO–SiO2 glass-ceramics. J. Non Cryst. Solids 2001, 292, 115–126. [Google Scholar] [CrossRef]
  6. Miguez-Pacheco, V.; Hench, L.L.; Boccaccini, A.R. Bioactive glasses beyond bone and teeth: Emerging applications in contact with soft tissues. Acta Biomater. 2015, 13, 1–15. [Google Scholar] [CrossRef] [PubMed]
  7. Tallawi, M.; Rosellini, E.; Barbani, N.; Cascone, M.G.; Rai, R.; Saint-Pierre, G.; Boccaccini, A.R. Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: A review. J. R. Soc. Interface 2015, 12, 20150254. [Google Scholar] [CrossRef] [PubMed]
  8. Lee, H.; Dellatore, S.M.; Miller, W.M.; Messersmith, P.B. Mussel-inspired surface chemistry for multifunctional coatings. Science 2007, 318, 426–430. [Google Scholar] [CrossRef] [PubMed]
  9. Liu, Y.; Ai, K.; Lu, L. Polydopamine and its derivative materials: Synthesis and promising applications in energy, environmental, and biomedical fields. Chem. Rev. 2014, 114, 5057–5115. [Google Scholar] [CrossRef] [PubMed]
  10. Ho, C.C.; Ding, S.J. Structure, properties and applications of mussel-inspired polydopamine. J. Biomed. Nanotechnol. 2014, 10, 3063–3084. [Google Scholar] [CrossRef] [PubMed]
  11. Mondin, G.; Wisser, F.M.; Leifert, A.; Mohamed-Noriega, N.; Grothe, J.; Dörfler, S.; Kaskel, S. Metal deposition by electroless plating on polydopamine functionalized micro- and nanoparticles. J. Colloid Interface Sci. 2013, 411, 187–193. [Google Scholar] [CrossRef] [PubMed]
  12. Schaubroeck, D.; Mader, L.; Dubruel, P.; Vanfleteren, J. Surface modification of an epoxy resin with polyamines and polydopamine: Adhesion toward electroless deposited copper. Appl. Surf. Sci. 2015, 353, 238–244. [Google Scholar] [CrossRef]
  13. Morones, J.R.; Elechiguerra, J.L.; Camacho, A.; Holt, K.; Kouri, J.B.; Ramírez, J.T.; Yacaman, M.J. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16, 2346–2353. [Google Scholar] [CrossRef] [PubMed]
  14. Lara, H.H.; Ayala-Núñez, N.V.; del Turrent, L.C.I.; Padilla, C.R. Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria. World J. Microbiol. Biotechnol. 2010, 26, 615–621. [Google Scholar] [CrossRef]
  15. Panácek, A.; Smékalová, M.; Kilianová, M.; Prucek, R.; Bogdanová, K.; Věcěrová, R.; Kolár, M.; Havrdová, M.; Płaza, G.A.; Chojniak, J.; et al. Strong and nonspecific synergistic antibacterial efficiency of antibiotics combined with silver nanoparticles at very low concentrations showing no cytotoxic effect. Molecules 2016, 21, 26. [Google Scholar] [CrossRef] [PubMed]
  16. Blaker, J.J.; Nazhat, S.N.; Boccaccini, A.R. Development and characterisation of silver-doped bioactive glass-coated sutures for tissue engineering and wound healing applications. Biomaterials 2004, 25, 1319–1329. [Google Scholar] [CrossRef] [PubMed]
  17. Miola, M.; Ferraris, S.; di Nunzio, S.; Robotti, P.F.; Bianchi, G.; Fucale, G.; Maina, G.; Cannas, M.; Gatti, S.; Massé, A.; et al. Surface silver-doping of biocompatible glasses to induce antibacterial properties. Part II: Plasma sprayed glass-coatings. J. Mater. Sci. Mater. Med. 2009, 20, 741–749. [Google Scholar] [CrossRef] [PubMed]
  18. Ciraldo, F.E.; Liverani, L.; Gritsch, L.; Goldmann, W.H.; Boccaccini, A.R. Synthesis and characterization of silver-doped mesoporous bioactive glass and its applications in conjunction with electrospinning. Materials 2018, 11, 692. [Google Scholar] [CrossRef] [PubMed]
  19. Kawashita, M.; Tsuneyama, S.; Miyaji, F.; Kokubo, T.; Kozuka, H.; Yamamoto, K. Antibacterial silver-containing silica glass prepared by sol-gel method. Biomaterials 2000, 21, 393–398. [Google Scholar] [CrossRef]
  20. Di Nunzio, S.; Brovarone, C.V.; Spriano, S.; Milanese, D.; Verné, E.; Bergo, V.; Maina, G.; Spinelli, P. Silver containing bioactive glasses prepared by molten salt ion-exchange. J. Eur. Ceram. Soc. 2004, 24, 2935–2942. [Google Scholar] [CrossRef]
  21. Saidin, S.; Chevallier, P.; Kadir, M.R.A.; Hermawan, H.; Mantovani, D. Polydopamine as an intermediate layer for silver and hydroxyapatite immobilisation on metallic biomaterials surface. Mater. Sci. Eng. C 2013, 33, 4715–4724. [Google Scholar] [CrossRef]
  22. Li, M.; Liu, Q.; Jia, Z.; Xu, X.; Shi, Y.; Cheng, Y.; Zheng, Y. Polydopamine-induced nanocomposite Ag/CaP coatings on the surface of titania nanotubes for antibacterial and osteointegration functions. J. Mater. Chem. B 2015, 3, 8796–8805. [Google Scholar] [CrossRef]
  23. Wang, Z.; Ou, J.; Wang, Y.; Xue, M.; Wang, F.; Pan, B.; Li, C.; Li, W. Anti-bacterial superhydrophobic silver on diverse substrates based on the mussel-inspired polydopamine. Surf. Coat. Technol. 2015, 280, 378–383. [Google Scholar] [CrossRef]
  24. Forte, L.; Torricelli, P.; Bonvicini, F.; Boanini, E.; Gentilomi, G.A.; Lusvardi, G.; della Bella, E.; Fini, M.; Nepita, E.V.; Bigi, A. Biomimetic fabrication of antibacterial calcium phosphates mediated by polydopamine. J. Inorg. Biochem. 2018, 178, 43–53. [Google Scholar] [CrossRef] [PubMed]
  25. Sileika, T.S.; Kim, H.D.; Maniak, P.; Messersmith, P.B. Antibacterial performance of polydopamine-modified polymer surfaces containing passive and active components. ACS Appl. Mater. Interfaces 2011, 3, 4602–4610. [Google Scholar] [CrossRef] [PubMed]
  26. Tejido-Rastrilla, R.; Baldi, G.; Boccaccini, A.R. Ag containing polydopamine coating on a melt-derived bioactive glass-ceramic: Effect on surface reactivity. Ceram. Int. 2018, 44, 16083–16087. [Google Scholar] [CrossRef]
  27. Kokubo, T.; Takadama, H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 2006, 27, 2907–2915. [Google Scholar] [CrossRef] [PubMed]
  28. Zangmeister, R.A.; Morris, T.A.; Tarlov, M.J. Characterization of polydopamine thin films deposited at short times by autoxidation of dopamine. Langmuir 2013, 29, 8619–8628. [Google Scholar] [CrossRef] [PubMed]
  29. Spriano, S.; Chandra, V.S.; Cochis, A.; Uberti, F.; Rimondini, L.; Bertone, E.; Vitale, A.; Scolaro, C.; Ferrari, M.; Cirisano, F.; et al. How do wettability, zeta potential and hydroxylation degree affect the biological response of biomaterials? Mater. Sci. Eng. C 2017, 74, 542–555. [Google Scholar] [CrossRef] [PubMed]
  30. Bernsmann, F.; Frisch, B.; Ringwald, C.; Ball, V. Protein adsorption on dopamine-melanin films: Role of electrostatic interactions inferred from ζ-potential measurements versus chemisorption. J. Colloid Interface Sci. 2010, 344, 54–60. [Google Scholar] [CrossRef]
  31. Fu, J.; Chen, Z.; Wang, M.; Liu, S.; Zhang, J.; Zhang, J.; Han, R.; Xu, Q. Adsorption of methylene blue by a high-efficiency adsorbent (Polydopamine microspheres): Kinetics, isotherm, thermodynamics and mechanism analysis. Chem. Eng. J. 2015, 259, 53–61. [Google Scholar] [CrossRef]
  32. Su, L.; Yu, Y.; Zhao, Y.; Liang, F.; Zhang, X. Strong Antibacterial Polydopamine Coatings Prepared by a Shaking-assisted Method. Sci. Rep. 2016, 6, 24420. [Google Scholar] [CrossRef] [PubMed]
  33. Ball, V. Impedance spectroscopy and zeta potential titration of dopa-melanin films produced by oxidation of dopamine. Colloids Surf. A Phys. Eng. Asp. 2010, 363, 92–97. [Google Scholar] [CrossRef]
  34. Cazzola, M.; Corazzari, I.; Prenesti, E.; Bertone, E.; Vernè, E.; Ferraris, S. Bioactive glass coupling with natural polyphenols: Surface modification, bioactivity and anti-oxidant ability. Appl. Surf. Sci. 2016, 367, 237–248. [Google Scholar] [CrossRef]
  35. Suzuki, T.; Nishizawa, K.; Yokogawa, Y.; Nagata, F.; Kawamoto, Y.; Kameyama, T. Time-dependent variation of the surface structure of bioceramics in tissue culture medium and the effect on adhesiveness of cells. J. Ferment. Bioeng. 1996, 81, 226–232. [Google Scholar] [CrossRef]
  36. Ryu, J.; Ku, S.H.; Lee, H.; Park, C.B. Mussel-inspired polydopamine coating as a universal route to hydroxyapatite crystallization. Adv. Funct. Mater. 2010, 20, 2132–2139. [Google Scholar] [CrossRef]
  37. El-Ghannam, A.; Hamazawy, E.; Yehia, A. Effect of thermal treatment on bioactive glass microstructure, corrosion behavior ζ potential, and protein adsorption. J. Biomed. Mater. Res. 2001, 55, 387–395. [Google Scholar] [CrossRef]
  38. Lu, H.H.; Pollack, S.R.; Ducheyne, P. 45S5 Bioactive glass surface charge variations and the formation of a surface calcium phosphate layer in a solution containing fibronectin. J. Biomed. Mater. Res. 2001, 54, 454–461. [Google Scholar] [CrossRef]
  39. Zhang, C.; Gong, L.; Xiang, L.; Du, Y.; Hu, W.; Zeng, H.; Xu, Z.K. Deposition and Adhesion of Polydopamine on the Surfaces of Varying Wettability. ACS Appl. Mater. Interfaces 2017, 9, 30943–30950. [Google Scholar] [CrossRef]
  40. Sathishkumar, M.; Sneha, K.; Won, S.W.; Cho, C.W.; Kim, S.; Yun, Y.S. Cinnamon zeylanicum bark extract and powder mediated green synthesis of nano-crystalline silver particles and its bactericidal activity. Colloids Surf. B Biointerfaces 2009, 73, 332–338. [Google Scholar] [CrossRef]
  41. Roy, A.K.; Park, B.; Lee, K.S.; Park, S.Y.; In, I. Boron nitride nanosheets decorated with silver nanoparticles through mussel-inspired chemistry of dopamine. Nanotechnology 2014, 25, 445603. [Google Scholar] [CrossRef]
  42. Wang, J.; Rahman, M.F.; Duhart, H.M.; Newport, G.D.; Patterson, T.A.; Murdock, R.C.; Hussain, S.M.; Schlager, J.J.; Ali, S.F. Expression changes of dopaminergic system-related genes in PC12 cells induced by manganese, silver, or copper nanoparticles. Neurotoxicology 2009, 30, 926–933. [Google Scholar] [CrossRef]
  43. Rehman, M.A.U.; Ferraris, S.; Goldmann, W.H.; Perero, S.; Bastan, F.E.; Nawaz, Q.; di Confiengo, G.G.; Ferraris, M.; Boccaccini, A.R. Antibacterial and Bioactive Coatings Based on Radio Frequency Co-Sputtering of Silver Nanocluster-Silica Coatings on PEEK/Bioactive Glass Layers Obtained by Electrophoretic Deposition. ACS Appl. Mater. Interfaces 2017, 9, 32489–32497. [Google Scholar] [CrossRef] [PubMed]
  44. Verné, E.; Bretcanu, O.; Balagna, C.; Bianchi, C.L.; Cannas, M.; Gatti, S.; Vitale-Brovarone, C. Early stage reactivity and in vitro behavior of silica-based bioactive glasses and glass-ceramics. J. Mater. Sci. Mater. Med. 2009, 20, 75–87. [Google Scholar] [CrossRef] [PubMed]
  45. Vitale-Brovarone, C.; Verné, E.; Robiglio, L.; Martinasso, G.; Canuto, R.A.; Muzio, G. Biocompatible glass-ceramic materials for bone substitution. J. Mater. Sci. Mater. Med. 2008, 19, 471–478. [Google Scholar] [CrossRef] [PubMed]
  46. Ciraldo, F.E.; Boccardi, E.; Melli, V.; Westhauser, F.; Boccaccini, A.R. Tackling bioactive glass excessive in vitro bioreactivity: Preconditioning approaches for cell culture tests. Acta Biomater. 2018, 75, 3–10. [Google Scholar] [CrossRef] [PubMed]
  47. Nakamura, T.; Yamamuro, T.; Higashi, S.; Kokubo, T.; Itoo, S. A new glass-ceramic for bone replacement: Evaluation of its bonding to bone tissue. J. Biomed. Mater. Res. 1985, 19, 685–698. [Google Scholar] [CrossRef] [PubMed]
  48. Ozawa, S.; Kasugai, S. Evaluation of implant materials (hydroxyapatite, glass-ceramics, titanium) in rat bone marrow stromal cell culture. Biomaterials 1996, 17, 23–29. [Google Scholar] [CrossRef]
  49. Hench, L.L.; Paschall, H.A. Direct chemical bond of bioactive glass-ceramic materials to bone and muscle. J. Biomed. Mater. Res. 1973, 7, 25–42. [Google Scholar] [CrossRef]
  50. Deligianni, D.D.; Katsala, N.D.; Koutsoukos, P.G.; Missirlis, Y.F. Effect of surface roughness of hydroxyapatite on human bone marrow cell adhesion, proliferation, differentiation and detachment strength. Biomaterials 2001, 22, 87–96. [Google Scholar] [CrossRef]
  51. Shin, Y.M.; Lee, Y.B.; Shin, H. Time-dependent mussel-inspired functionalization of poly(l-lactide-co-e{open}-caprolactone) substrates for tunable cell behaviors. Colloids Surf. B Biointerfaces 2011, 87, 79–87. [Google Scholar] [CrossRef]
  52. Lynge, M.E. Recent developments in poly (dopamine)—Based coatings for biomedical applications. Nanomedicine 2015, 10, 2725–2742. [Google Scholar] [CrossRef]
  53. Chien, H.W.; Tsai, W.B. Fabrication of tunable micropatterned substrates for cell patterning via microcontact printing of polydopamine with poly(ethylene imine)-grafted copolymers. Acta Biomater. 2012, 8, 3678–3686. [Google Scholar] [CrossRef]
  54. Iqbal, Z.; Lai, E.P.C.; Avis, T.J. Antimicrobial effect of polydopamine coating on Escherichia coli. J. Mater. Chem. 2012, 22, 21608–21612. [Google Scholar] [CrossRef]
  55. Lim, K.; Chua, R.R.Y.; Ho, B.; Tambyah, P.A.; Hadinoto, K.; Leong, S.S.J. Development of a catheter functionalized by a polydopamine peptide coating with antimicrobial and antibiofilm properties. Acta Biomater. 2015, 15, 127–138. [Google Scholar] [CrossRef] [PubMed]
  56. He, S.; Zhou, P.; Wang, L.; Xiong, X.; Zhang, Y.; Deng, Y.; Wei, S. Antibiotic-decorated titanium with enhanced antibacterial activity through adhesive polydopamine for dental/bone implant Antibiotic-decorated titanium with enhanced antibacterial activity through adhesive polydopamine for dental/bone implant. J. R. Soc. Interface 2014, 11, 20140169. [Google Scholar] [CrossRef] [PubMed]
  57. Zhou, P.; Deng, Y.; Lyu, B.; Zhang, R.; Zhang, H.; Ma, H.; Lyu, Y.; Wei, S. Rapidly-Deposited Polydopamine Coating via High Temperature and Vigorous Stirring: Formation, Characterization and Biofunctional Evaluation. PLoS ONE 2014, 9, e113087. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Scanning electron microscopy (SEM) micrographs of uncoated BGC1 (A,B), BGC1@PDA (C,D), and BGC1@PDA@Ag (E,F).
Figure 1. Scanning electron microscopy (SEM) micrographs of uncoated BGC1 (A,B), BGC1@PDA (C,D), and BGC1@PDA@Ag (E,F).
Materials 12 00500 g001
Figure 2. Schematic representations of the origin of negative charge on the uncoated (BGC1) and coated (BGC1@PDA) surface in diluted SBF at pH ≈ 7.4.
Figure 2. Schematic representations of the origin of negative charge on the uncoated (BGC1) and coated (BGC1@PDA) surface in diluted SBF at pH ≈ 7.4.
Materials 12 00500 g002
Figure 3. pH variation of DMEM (left) and SBF (right) containing uncoated BGC1 pellets.
Figure 3. pH variation of DMEM (left) and SBF (right) containing uncoated BGC1 pellets.
Materials 12 00500 g003
Figure 4. Viability of MG-63 cells cultured onto BGC1, BGC1@PDA and BGC1@PDA@Ag samples for 48 hours. Significant differences are indicated in comparison to control: * p < 0.05, ** p < 0.01 and *** p < 0.001 (Tukey’s posthoc test).
Figure 4. Viability of MG-63 cells cultured onto BGC1, BGC1@PDA and BGC1@PDA@Ag samples for 48 hours. Significant differences are indicated in comparison to control: * p < 0.05, ** p < 0.01 and *** p < 0.001 (Tukey’s posthoc test).
Materials 12 00500 g004
Figure 5. Fluorescence microscope images on different representative samples showing the results of calcein-DAPI staining of MG-63 cells after 48 hours of direct culture.
Figure 5. Fluorescence microscope images on different representative samples showing the results of calcein-DAPI staining of MG-63 cells after 48 hours of direct culture.
Materials 12 00500 g005
Figure 6. Turbidity measurements on suspensions of both tested Staphylococcus carnosus and Escherichia coli strains in lysogeny broth (LB) medium on different samples, showing their different antibacterial effects.
Figure 6. Turbidity measurements on suspensions of both tested Staphylococcus carnosus and Escherichia coli strains in lysogeny broth (LB) medium on different samples, showing their different antibacterial effects.
Materials 12 00500 g006
Table 1. Roughness measurements of the different samples investigated.
Table 1. Roughness measurements of the different samples investigated.
-Ra (μm)Rmax (μm)
Sintered ceramic-glass pellets, uncoated (BGC1)1.4 ± 0.312 ± 5
BGC1 coated with polydopamine (BGC1@PDA)1.0 ± 0.28 ± 2
BGC1 coated with polydopamine and Ag (BGC1@PDA@Ag)0.8 ± 0.16.1 ± 0.3
Table 2. Surface zeta potential of the different samples investigated (measurements in simulated body fluid (SBF)).
Table 2. Surface zeta potential of the different samples investigated (measurements in simulated body fluid (SBF)).
-Initial ConditionsMeasurements in SBF
-pHConductivity (mS·m−1)pHZ (mV)
BGC17.3216.147.34 ± 0.01−120 ± 9
BGC1@PDA7.3316.847.33 ± 0.00−83 ± 1
BGC1@PDA@Ag7.3816.207.35 ± 0.00−98 ± 1

Share and Cite

MDPI and ACS Style

Tejido-Rastrilla, R.; Ferraris, S.; Goldmann, W.H.; Grünewald, A.; Detsch, R.; Baldi, G.; Spriano, S.; Boccaccini, A.R. Studies on Cell Compatibility, Antibacterial Behavior, and Zeta Potential of Ag-Containing Polydopamine-Coated Bioactive Glass-Ceramic. Materials 2019, 12, 500.

AMA Style

Tejido-Rastrilla R, Ferraris S, Goldmann WH, Grünewald A, Detsch R, Baldi G, Spriano S, Boccaccini AR. Studies on Cell Compatibility, Antibacterial Behavior, and Zeta Potential of Ag-Containing Polydopamine-Coated Bioactive Glass-Ceramic. Materials. 2019; 12(3):500.

Chicago/Turabian Style

Tejido-Rastrilla, Rocío, Sara Ferraris, Wolfgang H. Goldmann, Alina Grünewald, Rainer Detsch, Giovanni Baldi, Silvia Spriano, and Aldo R. Boccaccini. 2019. "Studies on Cell Compatibility, Antibacterial Behavior, and Zeta Potential of Ag-Containing Polydopamine-Coated Bioactive Glass-Ceramic" Materials 12, no. 3: 500.

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop